SEC 13F Intelligence

Decheng Capital Management III (Cayman), LLC / BDQM

Decheng Capital Management III (Cayman), LLC’s Albireo Pharma Inc Position

Does Decheng Capital Management III (Cayman), LLC own Albireo Pharma Inc (BDQM)? Not currently — the last reported position was 623.3K shares worth $13M in Q4 2022; the fund’s latest 13F (Q4 2023) no longer reports it.

Position Value
$13M
Q4 2022
Shares
623.3K
% of Portfolio
+5.04%
Quarters Held
4
position exited

Position History BDQM

Reported value by quarter
Q1 ’22: $15MQ1 ’22Q2 ’22: $10MQ2 ’22Q3 ’22: $12MQ3 ’22Q4 ’22: $13MQ4 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2022623.3K$13M+5.04%
Q3 2022623.3K$12M+4.38%
Q2 2022518.3K$10M+3.90%
Q1 2022518.3K$15M+4.74%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Decheng Capital Management III (Cayman), LLC’s full portfolio or all institutional holders of BDQM.